Acıbadem Healthcare Group
A Turkish private healthcare network operating hospitals, medical centers, laboratories, outpatient services and specialist care across several countries.
Last updated August 21, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Acıbadem Healthcare Group is a Turkish private healthcare network founded in 1991 in Istanbul's Acıbadem district by Mehmet Ali Aydınlar. The group developed from a hospital business into an integrated healthcare system comprising hospitals, medical centers, outpatient clinics, laboratories, medical technology, education, emergency and home healthcare, and supporting facility services. Its clinical scope includes general and specialist medicine, diagnostic imaging and laboratory testing, surgery, inpatient treatment, oncology, cardiovascular care, organ transplantation, reproductive medicine, sports medicine, orthopedics, neurosurgery and robotic surgery. The brand expanded rapidly in Turkey through the opening and enlargement of hospitals in Istanbul and other major cities, including Bursa, Ankara, Adana, Kayseri, Eskişehir, İzmir and Muğla. Its Istanbul network includes facilities associated with districts such as Altunizade, Bakırköy, Maslak, Kadıköy, Kozyatağı, Ataşehir, Atakent, Taksim, Kartal and Fulya. The group also developed specialized centers and advanced treatment capabilities in fields such as cancer care, transplantation, cardiac surgery, reproductive health and minimally invasive or robot-assisted procedures. Acıbadem offered shares in a public offering in 2000 and used the proceeds for investment and capacity growth. IHH Healthcare acquired a majority stake in 2011, initially taking approximately 60 percent. Following later share conversions, IHH's ownership rose to approximately 90 percent in 2018, bringing Acıbadem more fully into IHH's international healthcare portfolio. International expansion accelerated in 2016, when Acıbadem entered Bulgaria through the acquisition of the Tokuda Group and a majority interest in City Clinic, and entered North Macedonia through the acquisition of Sistina Hospital. The group opened Acıbadem International Medical Center in Amsterdam in 2017 and expanded into Serbia through Acıbadem Bel Medic in 2019. The network therefore combines Turkish hospitals with selected international hospitals, clinics and outpatient or diagnostic facilities. Acıbadem's broader ecosystem includes Acıbadem Mehmet Ali Aydınlar University, a private Istanbul institution focused on medicine, health sciences, pharmacy, dentistry, engineering and biomedical research. Other associated operations include laboratory and biobanking businesses such as Acıbadem Labmed, Labvital and LabCell; Acıbadem Technology, which develops hospital information systems; APlus, which provides facility management; and Acıbadem Mobile, which supports emergency and home healthcare. The group also operates an International Patient Center that coordinates treatment planning, travel, transfers, multilingual assistance and related services for overseas patients. The brand is positioned around integrated private healthcare, specialist expertise, advanced medical technology and international patient access. Its hospitals and laboratories have reported international and national quality accreditations, including Joint Commission International accreditation at multiple institutions and ISO 15189 certification associated with laboratory operations. The precise number of facilities, ownership interests and operating markets can change and should be checked against the group's latest disclosures.
History
Acıbadem Healthcare Group was founded in 1991 by Mehmet Ali Aydınlar in Istanbul's Acıbadem district. It entered Turkey's private healthcare market through a hospital operation and subsequently pursued expansion through new construction, facility development, acquisitions and integration. The group built a substantial presence in Istanbul, adding hospitals in districts including Altunizade, Bakırköy, Maslak, Kadıköy, Kozyatağı, Ataşehir, Atakent, Taksim, Kartal and Fulya. It later extended its network to cities such as Bursa, Ankara, Adana, Kayseri, Eskişehir, İzmir and Muğla. As the network matured, Acıbadem broadened its clinical capabilities beyond general hospital care. It developed specialist centers and programs in oncology, transplantation, cardiovascular medicine, cardiac surgery, reproductive medicine, sports medicine, neurosurgery, orthopedics and robotic surgery. Its technology-oriented clinical model has included advanced radiotherapy systems, image-guided treatment, robotic surgical platforms and integrated diagnostic services. The group also established interpretation and international-patient support services for patients traveling to Turkey for treatment. A public offering in 2000 supplied capital for further investment and capacity growth. In 2011, IHH Healthcare acquired a majority stake, initially reported at approximately 60 percent. Share conversions in 2018 increased IHH's ownership to approximately 90 percent. Acıbadem consequently became an important component of IHH's international healthcare portfolio while retaining its Turkish identity and operating brand. The group's international expansion accelerated in 2016. In Bulgaria, it acquired the Tokuda Group and took a majority interest in City Clinic, adding hospitals and medical centers. In the same year it entered North Macedonia by acquiring Sistina Hospital. In 2017, Acıbadem opened an outpatient and diagnostic facility in Amsterdam called Acıbadem International Medical Center. In 2019, it expanded into Serbia through Acıbadem Bel Medic. Acıbadem also developed an education, research and support-services ecosystem. Acıbadem Mehmet Ali Aydınlar University, founded in Istanbul in 2007, provides programs in medicine, health sciences, pharmacy, dentistry and health-related engineering, supported by a research and education hospital and specialized laboratories. Laboratory and biobanking operations, hospital information systems, facility management, emergency and home healthcare, and hospital project services complement the clinical network. The group has pursued international quality recognition through hospital accreditation and laboratory standards. Multiple institutions have reported Joint Commission International accreditation, while Labmed has been associated with ISO 15189 medical laboratory certification. Acıbadem's current facility portfolio and ownership structure remain subject to change, so the latest corporate disclosures should be consulted for definitive operational figures.
- 2019
Expansion into Serbia
[1]The group establishes Acıbadem Bel Medic through an acquisition in Serbia.
- 2018
IHH ownership rises
[1]Share conversions raise IHH Healthcare's ownership to approximately 90 percent.
- 2017
Amsterdam medical center opens
[1]Acıbadem opens an international outpatient and diagnostic facility in Amsterdam.
- 2016
Expansion into Bulgaria and North Macedonia
[1]Acıbadem enters Bulgaria through Tokuda and City Clinic transactions and enters North Macedonia through Sistina Hospital.
- 2011
IHH Healthcare takes a majority stake
[1]IHH Healthcare acquires an initial approximately 60 percent interest in Acıbadem.
- 2007
Acıbadem University is founded
[1]The group establishes a private university in Istanbul focused on health education, clinical training and biomedical research.
- 2000
Public offering supports investment
[1]Acıbadem offers shares publicly and uses the proceeds for network and capacity expansion.
- 1998
IVF services begin
[1]The group establishes its in vitro fertilization centers and begins developing reproductive-health services.
- 1991
Acıbadem Healthcare Group is founded
[1]Mehmet Ali Aydınlar establishes the group in Istanbul's Acıbadem district.
Products and positioning
Integrated, technology-oriented and premium private healthcare provider with a Turkish base and international reach.
Hospital services
Acıbadem Hospitals
The core Acıbadem hospital network provides inpatient care, emergency treatment, surgery, specialist consultations, intensive care, diagnostics and follow-up services. Facilities include general hospitals and institutions with focused capabilities in oncology, cardiovascular medicine, transplantation, reproductive medicine, orthopedics, neurosurgery and other specialties.
Healthcare services
Specialist medical services
Acıbadem delivers specialist care through hospital departments and dedicated centers. Clinical areas include cancer medicine, radiotherapy, cardiac intervention and surgery, organ transplantation, neurosurgery, orthopedics, sports medicine, dermatology, aesthetic surgery and preventive health assessments.
Diagnostics
Diagnostic services
The group provides laboratory testing, medical imaging and related diagnostic services through its hospitals, medical centers and laboratory network. These services support screening, diagnosis, treatment planning, monitoring and post-treatment follow-up.
Cancer care
Oncology and advanced radiotherapy
Acıbadem's oncology services combine medical oncology, radiation oncology and oncologic surgery, with specialist attention to areas such as neuro-oncology, breast cancer and pediatric oncology. Reported technologies include Gamma Knife, CyberKnife, MR-LINAC, TrueBeam, TomoTherapy and AI-supported adaptive radiotherapy systems.
Cardiovascular care
Cardiology and cardiovascular surgery
Cardiovascular services cover interventional cardiology, adult and pediatric cardiac surgery, congenital heart disease and neonatal cardiac care. The network has also reported capabilities including transcatheter aortic valve implantation, robotic-assisted bypass procedures and aortic valve reconstruction using the Ozaki technique.
Reproductive medicine · 1998
IVF and reproductive health
Acıbadem's reproductive-medicine centers provide in vitro fertilization and associated fertility services. Reported capabilities include Micro-TESE, preimplantation genetic diagnosis and embryo cryopreservation, supported by clinical assessment and fertility treatment planning.
Transplant medicine
Organ transplantation
Specialized transplant centers provide kidney, liver and bone-marrow transplantation, including autologous and allogeneic procedures. Kidney programs have reported laparoscopic and robotic approaches intended to reduce recovery burdens for donors and recipients.
Surgical services
Robotic surgery
Robot-assisted surgery is used across selected urology, gynecology, general surgery and cardiothoracic procedures. Orthopedic services have also reported use of robotic systems for selected hip and knee replacement operations.
Medical tourism
International Patient Center
The International Patient Center coordinates overseas patients' treatment inquiries, clinical planning, travel arrangements, airport reception, transfers, interpretation and hospital support. It functions as a coordination layer connecting international patients with Acıbadem facilities and clinical teams.
Healthcare education · 2007
Acıbadem Mehmet Ali Aydınlar University
The affiliated private university provides education in medicine, health sciences, pharmacy, dentistry and health-related engineering. Its research and education hospital, laboratories and research centers support clinical training and biomedical research.
Marketing campaigns
- International Patient Center
Turkey · International markets
Acıbadem developed coordinated international-patient services combining treatment planning, travel assistance, transfers, multilingual support and post-treatment coordination for patients seeking care in Turkey.
Outcome. Ongoing service platform
- FIFA Medical Centre of Excellence sports medicine program
Turkey · International sports medicine market
Acıbadem Fulya Hospital operates a sports medicine program recognized as a FIFA Medical Centre of Excellence, offering performance analysis, injury prevention and rehabilitation for professional and amateur athletes.
Outcome. Ongoing specialist service
Brand decisions
2019
Establish Acıbadem Bel Medic in SerbiaM&ABackground
The group continued its Balkan expansion after entering Bulgaria and North Macedonia.
Action taken
Acıbadem established Acıbadem Bel Medic in Serbia through an acquisition.
Aftermath
The transaction expanded the group's hospital and clinic network into Serbia.
2017
Open an Amsterdam outpatient and diagnostic centerStrategyBackground
Acıbadem continued to build an international presence while extending access to outpatient and diagnostic services.
Action taken
The group opened Acıbadem International Medical Center in Amsterdam.
Aftermath
The Amsterdam facility added a Netherlands-based outpatient and diagnostic presence to the network.
2016
Expand through Bulgarian and North Macedonian acquisitionsM&ABackground
Acıbadem sought to extend its private healthcare platform beyond Turkey into Southeast Europe.
Action taken
The group acquired the Tokuda Group and a majority interest in City Clinic in Bulgaria, and acquired Sistina Hospital in North Macedonia.
Aftermath
The transactions added hospitals and medical centers in both markets and broadened Acıbadem's regional footprint.
2011
IHH Healthcare acquires a majority stakeM&ABackground
Acıbadem had developed into a significant Turkish private healthcare network and became part of IHH Healthcare's international expansion.
Action taken
IHH Healthcare acquired an initial approximately 60 percent interest in Acıbadem.
Aftermath
Acıbadem operated within the IHH Healthcare system, with IHH's ownership later increasing through share conversions.
2000
Use public-offering proceeds for network expansionStrategyBackground
The group sought additional capital as it expanded its private healthcare capacity in Turkey.
Action taken
Acıbadem conducted a public offering and directed the proceeds toward new investments and capacity increases.
Aftermath
The offering supported the subsequent development of the group's hospital and healthcare network.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/acıbadem-healthcare-group · Editorial policy · How profiles are compiled